LAUNCH DIAGNOSTICS, which provides innovative molecular diagnostics solutions for MRSA and C. difficile testing, is announcing the launch of Illumigene from Meridian Biosciences and will be demonstrating a sensitive, rapid, and easy test for detection of toxigenic C. difficile in stool samples.
Visitors to the stand can find out how a combination of molecular targets can be employed to provide fast, sensitive detection of MRSA while excluding isolates that do not have the fully functional resistance sequence. Detect-Ready MRSA Real Time PCR is a quadruplex assay giving rapid, highly accurate results from nasal swabs.
